Age-dependent changes in vancomycin-induced nephrotoxicity in mice
暂无分享,去创建一个
Jaewon Lee | A. Ishigami | T. Arai | Hirofumi Masutomi | T. Ishii | Y. Mori | M. Takigawa | Yoshitomo Shimazaki
[1] Jaewon Lee,et al. Time-Dependent Alterations of Vancomycin-Induced Nephrotoxicity in Mice. , 2017, Biological & pharmaceutical bulletin.
[2] T. Yano,et al. Vancomycin induces reactive oxygen species‐dependent apoptosis via mitochondrial cardiolipin peroxidation in renal tubular epithelial cells , 2017, European journal of pharmacology.
[3] R. Sawyer,et al. Vancomycin-Associated Nephrotoxicity: The Obesity Factor. , 2015, Surgical infections.
[4] Katsunori Furuta,et al. Pharmacodynamics of vancomycin in elderly patients aged 75 years or older with methicillin-resistant Staphylococcus aureus hospital-acquired pneumonia , 2013, Clinical interventions in aging.
[5] A. Nishikawa,et al. Proliferative and Nonproliferative Lesions of the Rat and Mouse Urinary System , 2012, Toxicologic pathology.
[6] T. Yano,et al. Mitochondrial superoxide production contributes to vancomycin-induced renal tubular cell apoptosis. , 2012, Free radical biology & medicine.
[7] Geoffrey S. Teehan,et al. Biopsy-proven vancomycin-associated interstitial nephritis and acute tubular necrosis , 2012, Clinical and Experimental Nephrology.
[8] L. Truong,et al. Role of immunohistochemistry in diagnosing renal neoplasms: when is it really useful? , 2012, Archives of pathology & laboratory medicine.
[9] H. Khalili,et al. Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review , 2012, European Journal of Clinical Pharmacology.
[10] H. Sokol,et al. Biopsy-proven anuric acute tubular necrosis associated with vancomycin and one dose of aminoside. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[11] Y. Kagawa,et al. Clinical efficacy of therapeutic drug monitoring in patients receiving vancomycin. , 2003, Biological & pharmaceutical bulletin.
[12] K. Rodvold,et al. Pharmacokinetics and Administration Regimens of Vancomycin in Neonates, Infants and Children , 1997, Clinical pharmacokinetics.
[13] J. Fortún,et al. The comparative efficacy and safety of teicoplanin and vancomycin. , 1996, The Journal of antimicrobial chemotherapy.
[14] M. Lindstrom,et al. Risk of Nephrotoxicity with Combination Vancomycin‐Aminoglycoside Antibiotic Therapy , 1990, Pharmacotherapy.
[15] C. A. Wood,et al. Vancomycin enhancement of experimental tobramycin nephrotoxicity , 1986, Antimicrobial Agents and Chemotherapy.
[16] D. Levine,et al. Vancomycin: a history. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[17] I. Naruse,et al. Antibody against single-stranded DNA detects both programmed cell death and drug-induced apoptosis , 2004, Histochemistry.
[18] Gary A. Boorman,et al. Pathology of the Mouse: Reference and Atlas , 1999 .